June Y. Hou, MD

Expertise in: 
Gynecological Oncology, Gynecologic Cancers, Cancer Care
Board Certifications: 
Obstetrics and Gynecology, Hospice and Palliative Medicine
Accepting New Patients
Profile Hero

Overview

Areas of Expertise / Conditions Treated

Gynecological Oncology, Gynecologic Cancers, Cancer Care, Hospice and Palliative Medicine, Oncology, Gynecologic, Robotic Surgery - Gynecologic Onc., Palliative Care (Hospice Care), Da Vinci Robotic Surgery, Female Pelvic Surgery, Laparoscopic Gynecologic Surgery, Gynecological Oncology Surgery, da Vinci Robotic Surgery Gyn Proced

Academic Appointments

  • Assistant Professor of Obstetrics & Gynecology at CUMC

June Hou, MD - Gynecologic Oncologist at ColumbiaDoctors

Dr. June Y. Hou received her undergraduate degree at Yale College with Honors, and completed medical school at Georgetown University School of Medicine. After completing her residency training at Yale New Haven Hospital, she pursued a gynecologic oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center. She is board certified in Obstetrics and Gynecology, Gynecologic Oncology, and Palliative Medicine.

She joins the faculty at Columbia University Medical Center with a research interest in early phase clinical trials, and quality of life measures in patients undergoing clinical trials for gynecologic malignancies. A past recipient of a career development grant focusing on molecular pathogenesis of ovarian cancer and rare uterine cancers, Dr. Hou has given multiple nationally-recognized presentations based on her work, and has lead numerous clinical trials. Clinically, Dr. Hou is certified in minimally invasive surgery, including robotic-assisted surgery. Her expertise includes chemotherapeutics and complex pelvic surgeries. Her goal is to provide compassionate and individualized care to all women with pre-malignant or gynecological cancers.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-3410

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, Georgetown University School of Medcine
  • Residency: Yale-New Haven Hospital
  • Fellowship: Albert Einstein / Montefiore Medical Center

Board Certifications

  • Obstetrics and Gynecology
  • Hospice and Palliative Medicine

Research

Grants

A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS (P&S Industry Clinical Trial)

Jun 1 2017 - Jun 30 2022